Flyte, a subsidiary of Catheter Precision, Inc. (NYSE American: VTAK), reported that its digital private aviation booking platform generated more than $1.0 million in revenue and added over 1,000 new users during the first six months of 2026, according to a press release.

The platform facilitated 118 flights across its network during that period. Flyte operates exclusively through a fleet of Cirrus Vision Jets and conducts flight operations via its wholly owned subsidiary, Ponderosa Air, LLC, an FAA-certified Part 135 air carrier.

The platform allows customers to book an entire aircraft online with fixed pricing and no membership requirement. It also supports aviation brokers and travel advisors through standardized pricing on select routes and an online quoting process.

Marc Sellouk, Founder and CEO of Flyte, said: "The early results from our technology platform have been extremely encouraging. We are seeing strong growth from both customers booking directly with Flyte and from our expanding network of broker and strategic partners."

The company stated in its forward-looking disclosures that it expects approximately $760,000 in Flyte-related revenue for the second quarter and projects revenue to increase 150% quarter-over-quarter, though such statements carry inherent uncertainty.

Flyte uses AI-enabled pricing and customer acquisition tools, along with digital marketing, geo-targeted campaigns, and influencer partnerships to drive bookings. The platform focuses on short-haul routes serving high-demand travel markets, utilizing smaller private airports.

Catheter Precision is a U.S.-based medical device company focused on cardiac arrhythmia treatment. Flyte represents a separate operating subsidiary within the company's portfolio.